AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-κB Pathway

Table 1

Relationship between AEBP1 expression and clinicopathological features in GBM patients.

Pathological factors		High AEBP1 expression	Low AEBP1 expression
Gender
Male	27	15	12
Female	24	11	13	0.488
Age
<50 years old	20	11	9
≥50 years old	31	15	16	0.645
IDH1 mutation
Yes	14	6	8
No	37	20	17	0.475
Maximum tumor diameter
<5 cm	23	6	17
≥5 cm	28	20	8	0.036
Tumor location
Supratentorial	29	17	12
Infratentorial	22	9	13	0.210

Statistical analysis was performed using the chi-square test.